share_log

Chief Operating Officer Christian Voigtlander Sold A Bunch Of Shares In ICU Medical

Chief Operating Officer Christian Voigtlander Sold A Bunch Of Shares In ICU Medical

首席運營官克里斯蒂安·沃伊特蘭德出售了重症監護病房醫療的大量股份
Simply Wall St ·  03/07 05:57

Some ICU Medical, Inc. (NASDAQ:ICUI) shareholders may be a little concerned to see that the Chief Operating Officer, Christian Voigtlander, recently sold a substantial US$1.5m worth of stock at a price of US$107 per share. Probably the most concerning element of the whole transaction is that the disposal amounted to 100% of their entire holding.

一些ICU Medical, Inc.(納斯達克股票代碼:ICUI)的股東可能會有點擔心,首席運營官克里斯蒂安·沃伊特蘭德最近以每股107美元的價格出售了價值150萬美元的大量股票。整個交易中最令人擔憂的因素可能是處置佔其全部持股的100%。

ICU Medical Insider Transactions Over The Last Year

去年的重症監護病房醫療內幕交易

Notably, that recent sale by Christian Voigtlander is the biggest insider sale of ICU Medical shares that we've seen in the last year. That means that an insider was selling shares at around the current price of US$104. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

值得注意的是,克里斯蒂安·沃伊特蘭德最近的出售是我們在去年看到的最大規模的ICU Medical股票內幕出售。這意味着一位內部人士正在以目前的104美元左右的價格出售股票。雖然我們通常不喜歡看到內幕銷售,但更令人擔憂的是是否以較低的價格進行銷售。鑑於此次出售是以當前價格進行的,這使我們有點謹慎,但並不是一個主要問題。

ICU Medical insiders didn't buy any shares over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

去年,ICU Medical的內部人士沒有購買任何股票。您可以看到下圖所示的去年的內幕交易(公司和個人)。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!

insider-trading-volume
NasdaqGS:ICUI Insider Trading Volume March 7th 2024
納斯達克GS:ICUI 內幕交易量 2024 年 3 月 7 日

I will like ICU Medical better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我看到一些重大的內幕收購,我會更喜歡ICU Medical。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。

Does ICU Medical Boast High Insider Ownership?

ICU Medical擁有很高的內部所有權嗎?

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. ICU Medical insiders own about US$152m worth of shares (which is 6.1% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

許多投資者喜歡查看公司內部人士擁有多少股份。我們通常希望看到相當高的內部所有權水平。ICU Medical內部人士擁有價值約1.52億美元的股份(佔該公司的6.1%)。我喜歡看到這種程度的內部所有權,因爲它增加了管理層考慮股東最大利益的機會。

What Might The Insider Transactions At ICU Medical Tell Us?

ICU Medical 的內幕交易可能會告訴我們什麼?

An insider sold ICU Medical shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For example, ICU Medical has 2 warning signs (and 1 which is a bit unpleasant) we think you should know about.

一位內部人士最近出售了ICU Medical的股票,但他們沒有購買任何股票。展望過去的十二個月,我們的數據並未顯示任何內幕買盤。儘管內部人士確實擁有該公司的大量股份(這很好),但我們對他們交易的分析並不能使我們對公司充滿信心。雖然我們喜歡了解內部人士的所有權和交易情況,但在做出任何投資決策之前,我們一定要考慮股票面臨的風險。例如,ICU Medical 有 2 個警告信號(以及 1 個有點不愉快),我們認爲你應該知道。

But note: ICU Medical may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意:ICU Medical可能不是最好的買入股票。因此,來看看這份投資回報率高、債務低的有趣公司的免費清單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論